| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 4290 | Null | 0.0220039422291541 | 0.046032793 |
| NSC 47786 | 9H-Purin-2-amine, 6-[[(2,4-dichlorophenyl)methyl]thio]-9-(2-methylpropyl)- | 0.0220039422291541 | 0.01429071 |
| NSC 624114 | Null | 0.0220039422291541 | -0.049819609 |
| NSC 665925 | Null | 0.0220039422291541 | 0.1258984 |
| NSC 633781 | 1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate | 0.0228506033927954 | -0.10771063 |
| NSC 101003 | Null | 0.0228506033927957 | 0.33224544 |
| NSC 731131 | 2-[4-(fluoro)benzylamino]-3-phenyl-5,7-diaminoquinoxaline | 0.0260391472224207 | -0.20556528 |
| NSC 750493 | 2-(2-hydroxyphenyl)-3-[5-(1H-imidazol-1-ylmethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazolidin-4-one | 0.0260391472224207 | 0.10104699 |
| NSC 105827 | SANGIVAMYCIN,-THIO | 0.0267520285931239 | 0.13858212 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0267520285931239 | 0.037818958 |